Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial

Absztrakt
Leírás
Kulcsszavak
Forrás
BMJ Open Ophthalmology. -8 : 1 (2023), p. 1-10. -(cikkazonosító)e001561. -BMJ Open Ophth. - 2397-3269